Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Synthetic Cannabinoids Market?
In recent years, an accelerated growth has been observed in the synthetic cannabinoids market’s size. The market, which is projected to expand from $1.88 billion in 2024 to $2.2 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 17.1%. Increased demand for substitute drugs, a rise in the number of cannabis users, expanding applications in the pharmaceutical industry, growing demand for legalized highs, and a trend towards self-medication are some of the factors linked with the notable growth in the historic period.

The market for synthetic cannabinoids is projected to experience significant expansion in the coming years, with a projected value of $4.19 billion by 2029, reflecting a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this growth are the increasing popularity of designer drugs, more prevalent legalization of cannabis, improved online availability of synthetic drugs, a spike in the popularity of vaping, and an uptick in the customization of cannabinoid products. Key trends predicted for the forecast period include more advanced forensic toxicology practices, the application of machine learning in detecting chemical patterns, the use of cloud technology for tracking illicit drugs, breakthroughs in synthetic cannabinoid formulations, and the creation of innovative cannabinoid analogs.

Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23536&type=smp

What Drivers Are Accelerating Expansion Of The Synthetic Cannabinoids Market?
An escalating necessity for therapies for neurological conditions is anticipated to spur the expansion of the synthetic cannabinoids market in future. Neurological conditions, which affect the brain, spinal cord, and nerves, impede movement, perception, cognition, or general functioning. The surge in occurrences of these disorders is largely dependent on the maturing global populace, as diseases such as Alzheimer’s increase in prevalence with age due to the brain’s natural aging process and accumulated cellular damage. Synthetic cannabinoids interact with cannabinoid receptors in the brain, modulating neurotransmitter activity and potentially relieving symptoms correlated with neurological diseases. For example, as per data from the European Brain Council, a health organization based in Belgium, there were 7 million Alzheimer’s patients in Europe as of September 2024. This figure is expected to double to 14 million by 2030 due to an aging population, symbolizing a substantial worldwide public health obstacle. Thus, an escalating necessity for therapies for neurological conditions is the key driving force behind the expansion of the synthetic cannabinoids market.

How Is The Global Synthetic Cannabinoids Market Broken Down By Segment?
The synthetic cannabinoids market covered in this report is segmented –

1) By Product Type: High-Pure Synthetic Cannabinoids, Ultra-Pure Synthetic Cannabinoids
2) By Formulation: Oil, Capsules, Edibles, Vapes, Topicals
3) By Indication: Pain Management, Nausea Or Vomiting, Neurological Disorder Management, Other Indications
4) By Application: Pharmaceuticals, Research, Recreational Use, Agriculture, Nutraceuticals
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By High-Pure Synthetic Cannabinoids: Pharmaceutical-Grade Cannabinoids, Research-Grade Cannabinoids, Industrial-Use Cannabinoids
2) By Ultra-Pure Synthetic Cannabinoids: Medical-Grade Cannabinoids, Biotechnology-Grade Cannabinoids, Analytical-Standard Cannabinoids

Which Trends Are Likely To Redefine Growth Paths In The Synthetic Cannabinoids Market?
Prominent firms in the synthetic cannabinoids market are concentrating on devising sophisticated solutions, like fungal expression systems, to improve the efficacy of production and curtail expenses. Genetically modified fungi are utilized in fungal expression systems to bioengineer synthetic cannabinoids, thereby presenting an environment-friendly and expandable alternative to chemical compound synthesis or extracting from plants. For pharmaceutical and research applications, these systems facilitate the production of high-purity compounds. For instance, in January 2022, Dyadic International Inc., a bio-tech firm based in the United States, presented a C1-cell protein production mechanism to generate synthetic cannabinoids. The groundbreaking approach uses filamentous fungal cell factories to produce cannabinoids like cannabidiol (CBD) and its forerunners in a more economical and sustainable manner. The method is energy-efficient and environmentally sustainable, offering the possibility of producing cleaner, regulation-compliant cannabinoids with potential therapeutic uses for medical conditions such as chronic pain, inflammation, and others.

Who Are The Global Leaders Steering The Synthetic Cannabinoids Market Forward?
Major companies operating in the synthetic cannabinoids market are Johnson Matthey, Harmony Biosciences, BioVectra, Restek Corporation, Noramco Inc., Cayman Chemical, Cerilliant Corporation, Skye Bioscience, Purisys LLC, Chiron AS, Lygos Inc., Botanix Pharmaceuticals, CB Therapeutics Inc., BayMedica, Zynerba Pharmaceuticals Inc., Kannalife Sciences Inc., SciSparc Ltd., 180 Life Science, Tetra Bio-Pharma Inc., Canntab Therapeutics Ltd.

Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/synthetic-cannabinoids-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Synthetic Cannabinoids Market?
North America was the largest region in the synthetic cannabinoids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the synthetic cannabinoids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=23536&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model